The role of complement regulatory proteins in peripheral blood cells of patients with systemic lupus erythematosus: review.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Cellular Immunology

• Publication date

  2012-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cellimm.2012.06.008PMID 22795896
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The management of peripheral blood cytopenias in systemic lupus erythematosus.

  2010cited by this paper
• The role of defective clearance of apoptotic cells in systemic autoimmunity

  2010cited by this paper
• Therapeutic potential of complement modulation

  2010cited by this paper
• Complement regulator CD46 temporally regulates cytokine production by conventional and unconventional T cells

  2010cited by this paper
• Complement: a key system for immune surveillance and homeostasis

  2010cited by this paper
• Complement control protein factor H: the good, the bad, and the inadequate.

  2010cited by this paper
• Complement and its role in innate and adaptive immune responses

  2010cited by this paper
• Expression of CD55 and CD59 on peripheral blood cells from systemic lupus erythematosus (SLE) patients.

  2010cited by this paper
• O papel das proteínas reguladoras do complemento CD55/CD59 em células de sangue periférico de pacientes com lúpus eritematoso sistêmico

  2009cited by this paper
• Complement regulators and inhibitory proteins

  2009cited by this paper
• The role of mannose-binding lectin in systemic lupus erythematosus

  2008cited by this paper
• Complement evasion by human pathogens

  2008cited by this paper
• Complement Receptor 1: Disease associations and therapeutic implications

  2008cited by this paper
• Complement-Dependent Enhancement of CD8+ T Cell Immunity to Lymphocytic Choriomeningitis Virus Infection in Decay-Accelerating Factor-Deficient Mice1

  2007cited by this paper
• Complement receptors CD21 and CD35 in humoral immunity

  2007cited by this paper
• Modulation of CR1 transcript in systemic lupus erythematosus (SLE) by IFN-γ and immune complex

  2007cited by this paper
• Alternative roles for CD59.

  2007cited by this paper
• The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias.

  2007cited by this paper
• Modulation of CR1 transcript in systemic lupus erythematosus (SLE) by IFN-gamma and immune complex.

  2007cited by this paper
• Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare

  2006cited by this paper
• Membrane complement regulatory proteins.

  2006cited by this paper
• Deficiency of decay accelerating factor and CD59 leads to crisis in experimental myasthenia.

  2006cited by this paper
• Expression of Glycosylphosphatidylinositol-Anchored CD59 on Target Cells Enhances Human NK Cell-Mediated Cytotoxicity1

  2006cited by this paper
• Role of complement and other innate immune mechanisms in the removal of apoptotic cells.

  2006cited by this paper
• Systemic lupus erythematosus

  2006cited by this paper
• CD55 and CD59 deficiency in transplant patient populations: possible association with paroxysmal nocturnal hemoglobinuria-like symptoms in Campath-treated patients.

  2006cited by this paper
• Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia

  2006cited by this paper
• Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia.

  2006cited by this paper
• Complement-induced regulatory T cells suppress T-cell responses but allow for dendritic-cell maturation.

  2006cited by this paper
• Decay-accelerating factor modulates induction of T cell immunity

  2005cited by this paper
• PIG-A mutations in normal hematopoiesis.

  2004cited by this paper
• CD46: expanding beyond complement regulation.

  2004cited by this paper
• [Systemic lupus erythematosus].

  2004cited by this paper
• Regulation of B-cell activation by complement receptors CD21 and CD35.

  2003cited by this paper
• Human Herpesvirus 6 Variant A Glycoprotein H-Glycoprotein L-Glycoprotein Q Complex Associates with Human CD46

  2003cited by this paper
• Mannose‐binding lectin engagement with late apoptotic and necrotic cells

  2003cited by this paper
• Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus.

  2003cited by this paper
• An immunohistochemical study of the clearance of apoptotic cellular fragments

  2002cited by this paper
• Detection of CD55- and/or CD59-Deficient Red Cell Populations in Patients With Plasma Cell Dyscrasias

  2002cited by this paper
• Complement in glomerulonephritis

  2002cited by this paper
• CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b‐8 as well as C5b‐9

  2002cited by this paper
• Identification of the Streptococcal M Protein Binding Site on Membrane Cofactor Protein (CD46)1

  2002cited by this paper
• Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice.

  2002cited by this paper
• Disorders of the complement system: an overview.

  2002cited by this paper
• A standardized flow cytometric method for screening paroxysmal nocturnal haemoglobinuria (PNH) measuring CD55 and CD59 expression on erythrocytes and granulocytes.

  2001cited by this paper
• MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway.

  2001cited by this paper
• Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders.

  2001cited by this paper
• Complement. Second of two parts.

  2001cited by this paper
• Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes.

  2001cited by this paper
• Complement. First of two parts.

  2001cited by this paper
• Relative increase of granulocytes with a paroxysmal nocturnal haemoglobinuria phenotype in aplastic anaemia patients: 
the high prevalence at diagnosis

  2001cited by this paper
• Structure–function relationships of complement receptor type 1

  2001cited by this paper
• Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence

  2001cited by this paper
• Complement and innate immunity.

  2000cited by this paper
• Deficiency of Complement Defense Protein CD59 May Contribute to Neurodegeneration in Alzheimer's Disease

  2000cited by this paper
• Detection of small populations of CD59-deficient erythrocytes in patients with aplastic anemia or myelodysplastic syndrome and normal individuals.

  2000cited by this paper
• The role of complement in B cell activation and tolerance.

  2000cited by this paper
• Expression of complement regulatory proteins in diffuse proliferative glomerulonephritis

  2000cited by this paper
• CD59 cross‐linking induces secretion of APO2 ligand in overactivated human T cells

  2000cited by this paper
• Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin

  2000cited by this paper
• Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE)

  1999cited by this paper
• CD59‐deficient blood cells and PIG‐A gene abnormalities in Japanese patients with aplastic anaemia

  1999cited by this paper
• Decay Accelerating Activity of Complement Receptor Type 1 (CD35)

  1999cited by this paper
• Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients.

  1999cited by this paper
• The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF)

  1996cited by this paper
• Exogenous glycosyl phosphatidylinositol-anchored CD59 associates with kinases in membrane clusters on U937 cells and becomes Ca(2+)-signaling competent

  1995cited by this paper
• dra-related X adhesins of gestational pyelonephritis-associated Escherichia coli recognize SCR-3 and SCR-4 domains of recombinant decay-accelerating factor

  1995cited by this paper
• Nonimmune activation of the classical complement pathway.

  1993cited by this paper
• Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues

  1993cited by this paper
• Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE)

  1992cited by this paper
• CD58 and CD59 molecules exhibit potentializing effects in T cell adhesion and activation.

  1992cited by this paper
• Decay-accelerating factor expression on either effector or target cells inhibits cytotoxicity by human natural killer cells.

  1992cited by this paper
• Increased frequency of the long (S) allotype of CR1 (the C3b/C4b receptor, CD35) in patients with systemic lupus erythematosus

  1992cited by this paper
• Prevalence and significance of haematological abnormalities in patients with systemic lupus erythematosus.

  1991cited by this paper
• Decay-Accelerating Factor: Biochemistry, Molecular Biology, and Function

  1989cited by this paper
• Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.

  1989cited by this paper
• Decay-accelerating factor: biochemistry, molecular biology, and function.

  1989cited by this paper
• Analysis of the interactions between properdin, the third component of complement (C3), and its physiological activation products.

  1988cited by this paper
• Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids

  1987cited by this paper
• Antilymphocyte antibodies and systemic lupus erythematosus.

  1987cited by this paper
• Activation of the first component of complement.

  1987cited by this paper

• Combined transcriptomics and proteomics analysis reveals mechanisms underlying refractory lupus nephritis in children

  2025cites this paper
• Effect of pre- and post-migration neighborhood environment on migrants’ mental health: the case of Shenzhen, China

  2024cites this paper
• Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus

  2023cites this paper
• Red Blood Cells: Chasing Interactions

  2019cites this paper
• Influence of a Hyperglycemic Microenvironment on a Diabetic Versus Healthy Rat Vascular Endothelium Reveals Distinguishable Mechanistic and Phenotypic Responses

  2019cites this paper
• Absence of CD59 in Guinea Pigs: Analysis of the Cavia porcellus Genome Suggests the Evolution of a CD59 Pseudogene

  2018cites this paper
• The role of complement activation in rhabdomyolysis-induced acute kidney injury

  2018cites this paper
• Production of complement components by cells of the immune system

  2017cites this paper
• Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid

  2017cites this paper
• Dysregulation of mCD46 and sCD46 contribute to the pathogenesis of bullous pemphigoid

  2017cites this paper
• The complement system in systemic lupus erythematosus: an update

  2014cites this paper
• A novel CRIg‐targeted complement inhibitor protects cells from complement damage

  2014cites this paper
• HHV-6 and HHV-7 in Cardiovascular Diseases and Cardiomyopathies

  2014cites this paper
• Mononuclear cells from a rare blood donor, after freezing under good manufacturing practice conditions, generate red blood cells that recapitulate the rare blood phenotype

  2014cites this paper
• Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura

  2014cites this paper
• Antigen-antibody complex stimulation of dendritic cells

  2013cites this paper